Papers

3

Total Citations

25

H-Index

3

About

Jeffrey J. Tosoian is a leading urologic oncologist and researcher whose work bridges cutting-edge robotics, microfluidics, and prostate cancer care. His research spans two transformative frontiers: the development of wireless microfluidics-enabled soft robots for targeted biofluid sampling and drug delivery, and the refinement of robotic-assisted radical prostatectomy for prostate cancer treatment. His 2025 paper on wireless microfluidics-enabled miniature soft robots (10 citations) introduces a novel platform for multimodal locomotion and fluid manipulation, promising to revolutionize diagnostics in hard-to-reach anatomical sites. Earlier, his 2012 comparison of open versus robotic radical retropubic prostatectomy (9 citations) provided critical evidence supporting the robotic approach as a standard of care for localized prostate cancer. Tosoian also contributed a 2022 case series on prostate cancer with peritoneal carcinomatosis (6 citations), documenting rare but aggressive disease presentations managed with robotic surgery. With a career defined by integrating advanced engineering with clinical urology, Tosoian’s work has garnered attention for its potential to improve both surgical outcomes and minimally invasive diagnostic capabilities. His research continues to shape the future of urologic oncology and soft robotics.

Research Focus

Key Achievements

3
H-Index
3
Papers
25
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Wireless microfluidics-enabled multifunctional miniature soft robots with multimodal locomotion for fluid manipulation
10 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Vanderbilt University, Johns Hopkins University, University of Michigan–Ann Arbor

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago